These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26490636)

  • 1. Cell-autonomous requirement for TCF1 and LEF1 in the development of Natural Killer T cells.
    Berga-Bolaños R; Zhu WS; Steinke FC; Xue HH; Sen JM
    Mol Immunol; 2015 Dec; 68(2 Pt B):484-9. PubMed ID: 26490636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tcf1 and Lef1 transcription factors establish CD8(+) T cell identity through intrinsic HDAC activity.
    Xing S; Li F; Zeng Z; Zhao Y; Yu S; Shan Q; Li Y; Phillips FC; Maina PK; Qi HH; Liu C; Zhu J; Pope RM; Musselman CA; Zeng C; Peng W; Xue HH
    Nat Immunol; 2016 Jun; 17(6):695-703. PubMed ID: 27111144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells.
    Xing S; Gai K; Li X; Shao P; Zeng Z; Zhao X; Zhao X; Chen X; Paradee WJ; Meyerholz DK; Peng W; Xue HH
    J Exp Med; 2019 Apr; 216(4):847-866. PubMed ID: 30837262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas.
    Tiemessen MM; Baert MR; Schonewille T; Brugman MH; Famili F; Salvatori DC; Meijerink JP; Ozbek U; Clevers H; van Dongen JJ; Staal FJ
    PLoS Biol; 2012; 10(11):e1001430. PubMed ID: 23185135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells.
    Steinke FC; Xue HH
    Immunol Res; 2014 Aug; 59(1-3):45-55. PubMed ID: 24847765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.
    Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH
    J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tcf1 and Lef1 provide constant supervision to mature CD8
    Shan Q; Li X; Chen X; Zeng Z; Zhu S; Gai K; Peng W; Xue HH
    Nat Commun; 2021 Oct; 12(1):5863. PubMed ID: 34615872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCF1 and LEF1 Control Treg Competitive Survival and Tfr Development to Prevent Autoimmune Diseases.
    Yang BH; Wang K; Wan S; Liang Y; Yuan X; Dong Y; Cho S; Xu W; Jepsen K; Feng GS; Lu LF; Xue HH; Fu W
    Cell Rep; 2019 Jun; 27(12):3629-3645.e6. PubMed ID: 31216480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of LEF1/TCFs family members in colonic carcinogenesis.
    Han W; He L; Cao B; Zhao X; Zhang K; Li Y; Beck P; Zhou Z; Tian Y; Cheng S; Wang H
    Mol Carcinog; 2017 Nov; 56(11):2372-2381. PubMed ID: 27433921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription factor lymphoid enhancer factor 1 controls invariant natural killer T cell expansion and Th2-type effector differentiation.
    Carr T; Krishnamoorthy V; Yu S; Xue HH; Kee BL; Verykokakis M
    J Exp Med; 2015 May; 212(5):793-807. PubMed ID: 25897173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.
    Noma H; Eshima K; Satoh M; Iwabuchi K
    Immunology; 2015 Sep; 146(1):89-99. PubMed ID: 25988531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell factor-1 controls the lifetime of CD4+ CD8+ thymocytes in vivo and distal T cell receptor α-chain rearrangement required for NKT cell development.
    Sharma A; Berga-Bolaños R; Sen JM
    PLoS One; 2014; 9(12):e115803. PubMed ID: 25536344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T
    Li F; Zhao X; Zhang Y; Shao P; Ma X; Paradee WJ; Liu C; Wang J; Xue HH
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33372138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of SLAM in NKT cell development revealed by transgenic complementation in NOD mice.
    Jordan MA; Fletcher JM; Jose R; Chowdhury S; Gerlach N; Allison J; Baxter AG
    J Immunol; 2011 Apr; 186(7):3953-65. PubMed ID: 21357537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax.
    Ma G; Yasunaga J; Akari H; Matsuoka M
    Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2216-21. PubMed ID: 25646419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network of high-mobility group box transcription factors programs innate interleukin-17 production.
    Malhotra N; Narayan K; Cho OH; Sylvia KE; Yin C; Melichar H; Rashighi M; Lefebvre V; Harris JE; Berg LJ; Kang J;
    Immunity; 2013 Apr; 38(4):681-93. PubMed ID: 23562159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells.
    Ngai H; Barragan GA; Tian G; Balzeau JC; Zhang C; Courtney AN; Guo L; Xu X; Wood MS; Drabek JM; Demberg T; Sands CM; Chauvin-Fleurence CN; Di Pierro EJ; Rosen JM; Metelitsa LS
    Cancer Immunol Res; 2023 Feb; 11(2):171-183. PubMed ID: 36484736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1.
    Okamura RM; Sigvardsson M; Galceran J; Verbeek S; Clevers H; Grosschedl R
    Immunity; 1998 Jan; 8(1):11-20. PubMed ID: 9462507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different behaviour of DVL1, DVL2, DVL3 in astrocytoma malignancy grades and their association to TCF1 and LEF1 upregulation.
    Kafka A; Bačić M; Tomas D; Žarković K; Bukovac A; Njirić N; Mrak G; Krsnik Ž; Pećina-Šlaus N
    J Cell Mol Med; 2019 Jan; 23(1):641-655. PubMed ID: 30468298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tcf1 Sustains the Expression of Multiple Regulators in Promoting Early Natural Killer Cell Development.
    Liu J; Wang Z; Hao S; Wang F; Yao Y; Zhang Y; Zhao Y; Guo W; Yu G; Ma X; Liu J; Chen F; Yuan S; Kang Y; Yu S
    Front Immunol; 2021; 12():791220. PubMed ID: 34917097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.